These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
310 related articles for article (PubMed ID: 19787814)
1. Ghrelin--a novel generation of anti-obesity drug: design, pharmacomodulation and biological activity of ghrelin analogues. Chollet C; Meyer K; Beck-Sickinger AG J Pept Sci; 2009 Nov; 15(11):711-30. PubMed ID: 19787814 [TBL] [Abstract][Full Text] [Related]
2. Growth hormone secretagogue receptor antagonists as anti-obesity therapies? Still an open question. Zhao H; Liu G Curr Opin Drug Discov Devel; 2006 Jul; 9(4):509-15. PubMed ID: 16889233 [TBL] [Abstract][Full Text] [Related]
3. Ghrelin control of GH secretion and feeding behaviour: the role of the GHS-R1a receptor studied in vivo and in vitro using novel non-peptide ligands. Bresciani E; Tamiazzo L; Torsello A; Bulgarelli I; Rapetti D; Caporali S; Perrissoud D; Moulin A; Fehrentz JA; Martinez J; Locatelli V Eat Weight Disord; 2008 Sep; 13(3):e67-74. PubMed ID: 19011367 [TBL] [Abstract][Full Text] [Related]
4. Targeting the ghrelin receptor to regulate food intake. Depoortere I Regul Pept; 2009 Aug; 156(1-3):13-23. PubMed ID: 19362579 [TBL] [Abstract][Full Text] [Related]
5. Recent developments in ghrelin receptor ligands. Moulin A; Ryan J; Martinez J; Fehrentz JA ChemMedChem; 2007 Sep; 2(9):1242-59. PubMed ID: 17520591 [TBL] [Abstract][Full Text] [Related]
6. Discovery and optimization of novel 4-[(aminocarbonyl)amino]-N-[4-(2-aminoethyl)phenyl]benzenesulfonamide ghrelin receptor antagonists. Pasternak A; Goble SD; deJesus RK; Hreniuk DL; Chung CC; Tota MR; Mazur P; Feighner SD; Howard AD; Mills SG; Yang L Bioorg Med Chem Lett; 2009 Nov; 19(21):6237-40. PubMed ID: 19767208 [TBL] [Abstract][Full Text] [Related]
8. Ghrelin: a new peptide regulating growth hormone release and food intake. De Vriese C; Delporte C Int J Biochem Cell Biol; 2008; 40(8):1420-4. PubMed ID: 17544318 [TBL] [Abstract][Full Text] [Related]
9. Lean mean fat reducing "ghrelin" machine: hypothalamic ghrelin and ghrelin receptors as therapeutic targets in obesity. Schellekens H; Dinan TG; Cryan JF Neuropharmacology; 2010 Jan; 58(1):2-16. PubMed ID: 19573543 [TBL] [Abstract][Full Text] [Related]
10. Heterogeneity of ghrelin/growth hormone secretagogue receptors. Toward the understanding of the molecular identity of novel ghrelin/GHS receptors. Muccioli G; Baragli A; Granata R; Papotti M; Ghigo E Neuroendocrinology; 2007; 86(3):147-64. PubMed ID: 17622734 [TBL] [Abstract][Full Text] [Related]
11. Ghrelin receptor: high constitutive activity and methods for developing inverse agonists. Els S; Beck-Sickinger AG; Chollet C Methods Enzymol; 2010; 485():103-21. PubMed ID: 21050913 [TBL] [Abstract][Full Text] [Related]
12. Ghrelin gene-related peptides: multifunctional endocrine / autocrine modulators in health and disease. Seim I; Amorim L; Walpole C; Carter S; Chopin LK; Herington AC Clin Exp Pharmacol Physiol; 2010 Jan; 37(1):125-31. PubMed ID: 19566830 [TBL] [Abstract][Full Text] [Related]
13. Modulation of the constitutive activity of the ghrelin receptor by use of pharmacological tools and mutagenesis. Mokrosiński J; Holst B Methods Enzymol; 2010; 484():53-73. PubMed ID: 21036226 [TBL] [Abstract][Full Text] [Related]
14. Characterization of new stable ghrelin analogs with prolonged orexigenic potency. Maletínská L; Pýchová M; Holubová M; Blechová M; Demianová Z; Elbert T; Železná B J Pharmacol Exp Ther; 2012 Mar; 340(3):781-6. PubMed ID: 22182933 [TBL] [Abstract][Full Text] [Related]
15. Ghrelin receptor inverse agonists: identification of an active peptide core and its interaction epitopes on the receptor. Holst B; Lang M; Brandt E; Bach A; Howard A; Frimurer TM; Beck-Sickinger A; Schwartz TW Mol Pharmacol; 2006 Sep; 70(3):936-46. PubMed ID: 16798937 [TBL] [Abstract][Full Text] [Related]
16. The 1,2,4-triazole as a scaffold for the design of ghrelin receptor ligands: development of JMV 2959, a potent antagonist. Moulin A; Brunel L; Boeglin D; Demange L; Ryan J; M'Kadmi C; Denoyelle S; Martinez J; Fehrentz JA Amino Acids; 2013 Feb; 44(2):301-14. PubMed ID: 22798076 [TBL] [Abstract][Full Text] [Related]
17. Functionally biased signalling properties of 7TM receptors - opportunities for drug development for the ghrelin receptor. Sivertsen B; Holliday N; Madsen AN; Holst B Br J Pharmacol; 2013 Dec; 170(7):1349-62. PubMed ID: 24032557 [TBL] [Abstract][Full Text] [Related]
18. Quinazolinone derivatives as orally available ghrelin receptor antagonists for the treatment of diabetes and obesity. Rudolph J; Esler WP; O'connor S; Coish PD; Wickens PL; Brands M; Bierer DE; Bloomquist BT; Bondar G; Chen L; Chuang CY; Claus TH; Fathi Z; Fu W; Khire UR; Kristie JA; Liu XG; Lowe DB; McClure AC; Michels M; Ortiz AA; Ramsden PD; Schoenleber RW; Shelekhin TE; Vakalopoulos A; Tang W; Wang L; Yi L; Gardell SJ; Livingston JN; Sweet LJ; Bullock WH J Med Chem; 2007 Oct; 50(21):5202-16. PubMed ID: 17887659 [TBL] [Abstract][Full Text] [Related]
19. Ghrelin and its biological effects on pigs. Dong XY; Xu J; Tang SQ; Li HY; Jiang QY; Zou XT Peptides; 2009 Jun; 30(6):1203-11. PubMed ID: 19463757 [TBL] [Abstract][Full Text] [Related]